Regarding the Separation of Dispensing and Prescribing (SDP) in Japan, there are some negative opinions that the value of separating these services has not been commensurate with the cost. On the other hand, there is substantial data showing the current state of SDP and its merits, which has been collected and published in academic journals. In 2019, the Japan Pharmaceutical Association searched for articles on this subject in domestic academic journals published over the past five years, and found that there were more than 300 articles that evaluated efforts to contribute to therapeutic efficacy and safety at pharmacies. Among these, some addressed the roles required of pharmacies in a community-based integrated care system, such as efforts toward coordinated medicine management of patients who visit multiple medical institutions, follow-up with patients receiving drug therapy, utilization of patient test values at pharmacies, and home medical care. These research results can be utilized in healthcare policy making. However, even with this volume of existing research, it is hard to determine whether such research is sufficient to connect these findings to measures that would improve policy issues. Therefore, it is necessary to identify for researchers the types of evidence that would help guide and formulate effective new SDP policies.
Keywords: Separation of Dispensing and Prescribing; pharmacist-led research activity; policy making.